MedTech company Miris On Worldwide Business with Kathy Ireland
Miris’ has developed the Human Milk Analyzer™ to improve global neonatal health. Miris CEO Camilla Myhre Sandberg, was exclusively interviewed by Kathy Ireland on Worldwide Business with Kathy Ireland. The show will be aired globally Bloomberg International on May 18 and 19.
Kathy Ireland met with Miris’ CEO, Camilla Myhre Sandberg, and discussed how Miris are enabling clinicians to give preterm babies the best possible start, by supporting growth and reducing potential health issues later in life. One important key success factor is individualized nutrition. Miris HMA™ measure the macronutrient composition of human milk to enable individual nutrition for preterm babies. In this way each preterm baby is given tailored nutrition, using target fortification of human milk.
- I really enjoyed speaking with Kathy about how analysing the macronutrient content in breastmilk can enable caregivers to target the fortification of the milk for each preemie to ensure they receive the nutritional content they need," says Camilla Myhre Sandberg. “There is no doubt that healthcare professionals in Sweden and in the U.S. agree that breastmilk is the best nutrition for preterm babies,” says Camilla. “Now that Miris HMA™ is cleared by FDA, US healthcare professionals can introduce targeted fortification by analysing the milk and add the right amount of protein and energy as needed for each premature baby. This is something which has been standard of care in Sweden for more than 10 years, says Camilla.”
For more information about Miris, visit mirissolutions.com or follow Miris on Facebook, Miris on Twitter, or visit Miris on LinkedIn. Tune in to Bloomberg International on Saturday, May 18, 2019 at 7:30pm GMT and Sunday, May 19, 2019 at 10:30am D.F. and 3:00pm HKT.
For more information: Camilla Myhre Sandberg, VD Miris Holding AB Cell phone: +46 18-14 69 07, email: firstname.lastname@example.org
About World Wide Business with kathy ireland®
Worldwide Business with kathy ireland® is a weekly business television program featuring real world insights from corporate executives from all over the globe which can be viewed on Fox Business Network as part of their sponsored programming lineup, as well as internationally to over 50 countries on Bloomberg International.
Miris is a global MedTech company who develops and sells solutions for human milk analysis. The products are used at neonatal intensive care units, milk banks and research centers worldwide. The purpose is to enable clinicians to practice individualized nutrition of breast milk using target fortification, thus giving preterm babies the best possible start in life. The Human Milk Analyzer™ (HMA) has been tested and approved in December 2018 by the FDA for the U.S. market. Miris mission is to make individualized nutrition, based on breast milk, available globally to improve neonatal health.